Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Colgate-Palmolive (NYSE:CL)

Core Insights - Colgate-Palmolive Company reported fourth-quarter adjusted earnings per share of 95 cents, exceeding the analyst consensus estimate of 91 cents [1] - The company achieved quarterly sales of $5.230 billion, surpassing the Street view of $5.118 billion [1] - CEO Noel Wallace highlighted that net sales and organic sales grew in every category during the quarter, particularly in oral care and pet nutrition, excluding private label [1] Financial Forecast - Colgate-Palmolive forecasts fiscal 2026 sales between $20.79 billion and $21.61 billion, compared to analysts' estimate of $20.98 billion [2] - Following the earnings announcement, Colgate-Palmolive shares increased by 2% to trade at $92.11 [2] - Analysts adjusted their price targets on Colgate-Palmolive after the earnings report [2]